Queen Mary Innovation Analysis
What is Queen Mary Innovation?
University-backed innovation hub with AI-driven medical diagnostics and spinout ventures
Location
London, United Kingdom
Employees
11-50
Founded
2007
Product Features & Capabilities
- AI-powered digital twin of aorta simulating blood flow
- Machine learning model predicting dementia nine years before symptoms
- Blood test for predicting pre-eclampsia five to sixteen weeks into pregnancy
- Single molecule biochips for real-time blood clotting diagnosis
- Novel electronic skin for robotics
- Peptide therapy for neovascular eye diseases
- Toothpaste tablet reducing plastic waste
- AI-powered music mastering and collaboration platform LANDR
- Advanced forming technology for synthetic heart valves in Syntex
Use Cases
Predict patient response to arthritis treatment using deep molecular phenotyping; Simulate blood flow in individual aortas with AI to guide TAVR procedures; Detect pre-eclampsia in early pregnancy with a blood test; Diagnose dementia with 80%+ accuracy up to nine years before symptoms; Enhance immunotherapy efficacy in lung cancer; Diagnose blood clotting issues in real time with portable biochips; Enable robotics to sense physical object properties with electronic skin; Provide appetite suppression via nutrient-based therapy elcella; Create sustainable packaging with biodegradable toothpaste tablets
Other Considerations
Operates as Queen Mary University’s official technology transfer company; Manages 15+ active research projects; Has 8+ spinout companies in development; Portfolio includes AI-driven medical diagnostics and sustainable consumer products; Active in biopharma, engineering, and humanities innovation areas
